Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysis
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 31 Aug 2016 Status changed from active, no longer recruiting to completed.
- 09 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 16 Jan 2015 New trial record